Table 1.

Demographics of total patient population

	Total					BT-naïve					BT-experienced
	ADL	IFX	SCK	UST	Sub total	ADL	IFX	SCK	UST	Sub total	ADL	IFX	SCK	UST	Sub total
Number of patients	42	52	21	90	205	37	48	13	79	177	5	4	8	11	28
Average Age	50.0	46.2	45.4	46.8	47.1	50.9	46.0	46.2	46.5	47.3	43.4	47.5	44.3	48.4	46.2
% Female	7.1%	21.2%	33.3%	17.8%	18.1%	8.1%	20.8%	46.2%	20.3%	19.8%	0.0%	25.0%	12.5%	0.0%	7.1%

ADL Adalimumab, IFX Infliximab, SCK Secukinumab, UST Ustekinumab